BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizuno M, Yatabe Y, Nawa A, Nakanishi T. Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma. Int J Clin Oncol 2012;17:348-54. [PMID: 21830086 DOI: 10.1007/s10147-011-0299-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Rahaman J, Cohen CJ. Gynecologic Sarcomas. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm108.pub2] [Reference Citation Analysis]
2 Huang X, Peng P. Hormone Therapy Reduces Recurrence in Stage II-IV Uterine Low-Grade Endometrial Stromal Sarcomas: A Retrospective Cohort Study. Front Oncol 2022;12:922757. [DOI: 10.3389/fonc.2022.922757] [Reference Citation Analysis]
3 Meng LL, Jia XP, Lu LX, Zhang HZ, Shen XH, Piao ZH, Ge R, Yu WY. Unusual morphologic features of low-grade endometrial stromal sarcoma: A case report. J Clin Lab Anal 2022;:e24502. [PMID: 35642882 DOI: 10.1002/jcla.24502] [Reference Citation Analysis]
4 Maccaroni E, Lunerti V, Agostinelli V, Giampieri R, Zepponi L, Pagliacci A, Berardi R. New Insights into Hormonal Therapies in Uterine Sarcomas. Cancers 2022;14:921. [DOI: 10.3390/cancers14040921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mitra S, Lami MS, Ghosh A, Das R, Tallei TE, Fatimawali, Islam F, Dhama K, Begum MY, Aldahish A, Chidambaram K, Emran TB. Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications? Cancers (Basel) 2022;14:759. [PMID: 35159024 DOI: 10.3390/cancers14030759] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
6 Wu Y, Li N, Zhang R, Bai P. Primary low-grade extrauterine endometrial stromal sarcoma: analysis of 10 cases with a review of the literature. World J Surg Oncol 2022;20:17. [PMID: 35027071 DOI: 10.1186/s12957-021-02474-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dai Q, Xu B, Wu H, You Y, Wu M, Li L. The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study. Orphanet J Rare Dis 2021;16:160. [PMID: 33827628 DOI: 10.1186/s13023-021-01802-8] [Reference Citation Analysis]
8 Friedlander M, Benson C, O'Connell RL, Reed N, Clamp A, Lord R, Millan D, Nottley S, Amant F, Steer C, Anand A, Mileshkin L, Beale P, Banerjee S, Bradshaw N, Kelly C, Carty K, Divers L, Alexander L, Edmondson R. Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903). Gynecol Oncol 2021;161:160-5. [PMID: 33608144 DOI: 10.1016/j.ygyno.2021.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Franchi, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia). Eur J Cancer 2020;139:149-68. [PMID: 32992154 DOI: 10.1016/j.ejca.2020.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Pannier D, Cordoba A, Ryckewaert T, Robin Y, Penel N. Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis. Critical Reviews in Oncology/Hematology 2019;143:62-6. [DOI: 10.1016/j.critrevonc.2019.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wu H, Luo Y, Yin N, Gui W, Cao Y. Vaginal endometrial stromal sarcoma: A literature review. Eur J Obstet Gynecol Reprod Biol X 2019;4:100094. [PMID: 31528854 DOI: 10.1016/j.eurox.2019.100094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zang Y, Dong M, Zhang K, Gao C, Guo F, Wang Y, Xue F. Hormonal therapy in uterine sarcomas. Cancer Med 2019;8:1339-49. [PMID: 30897294 DOI: 10.1002/cam4.2044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
13 Chin TH, Lin G, Wu RC, Lai CH. Recurrence after fertility-preserving surgery for low-grade endometrial stromal sarcoma. J Obstet Gynaecol Res 2018;44:1836-42. [PMID: 29974555 DOI: 10.1111/jog.13695] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Yuasa-shibasaki E, Ishii S, Matsumoto S, Tomaru T, Horiguchi K, Osaki A, Ozawa A, Shibusawa N, Satoh T, Yamada M. Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate. Intern Med 2018;57:545-549. [DOI: 10.2169/internalmedicine.9036-17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Jacob SS, Somashekhar SP, Jacob SS. Role of Hormone Replacement Therapy (HRT) in Gynecological Cancers: Endocrinologist’s Perspective. Indian J Gynecol Oncolog 2016;14:43. [DOI: 10.1007/s40944-016-0070-4] [Reference Citation Analysis]
16 Schoolmeester JK, Sciallis AP, Greipp PT, Hodge JC, Dal Cin P, Keeney GL, Nucci MR. Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall. Int J Gynecol Pathol 2015;34:576-83. [PMID: 26444253 DOI: 10.1097/PGP.0000000000000187] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
17 Boyd LR. Management of Uterine Sarcomas. Current Clinical Oncology 2016. [DOI: 10.1007/7631_2016_13] [Reference Citation Analysis]
18 Cuppens T, Tuyaerts S, Amant F. Potential Therapeutic Targets in Uterine Sarcomas. Sarcoma 2015;2015:243298. [PMID: 26576131 DOI: 10.1155/2015/243298] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
19 Wolfe H, Bunch K, Stany M. Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma. Gynecol Oncol Rep 2016;15:4-6. [PMID: 26937477 DOI: 10.1016/j.gore.2015.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Yamazaki H, Todo Y, Mitsube K, Hareyama H, Shimada C, Kato H, Yamashiro K. Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study. J Gynecol Oncol 2015;26:214-21. [PMID: 25925291 DOI: 10.3802/jgo.2015.26.3.214] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
21 Sommeijer DW, Sjoquist KM, Friedlander M. Hormonal treatment in recurrent and metastatic gynaecological cancers: a review of the current literature. Curr Oncol Rep 2013;15:541-8. [PMID: 24097282 DOI: 10.1007/s11912-013-0343-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
22 Miyamoto T, Tachibana R, Kobara H, Takano T, Kato H, Shimizu A, Ohya A, Uehara T, Shiozawa T. Recurrent low-grade endometrial stromal sarcoma with intracaval and intracardiac tumor thrombus: diagnosis, treatment, and surgical management. Int Canc Conf J 2014;3:1-7. [DOI: 10.1007/s13691-013-0134-6] [Reference Citation Analysis]
23 Inoue K, Tsubamoto H, Kawata S, Hao H, Ikeda Y, Oku N, Hirota S. 18 F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma: PET features and tumor biology of ESS. J Obstet Gynaecol Res 2014;40:576-82. [DOI: 10.1111/jog.12180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
24 Akashi D, Todo Y, Shimada C, Okamoto K, Minobe S, Kato H. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report. Jpn J Clin Oncol 2013;43:1145-9. [PMID: 24058200 DOI: 10.1093/jjco/hyt142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]